Radioactive orotic acid incorporation into RNA (de novo pathway of pyrimidine nucleotide synthesis) was considerably lower for rat heart than for rat liver in vivo and in vitro. S H uridine ("salvage" pathway) was incorporated into heart RNA to a greater extent than 3 H orotic acid, and the labeling with uridine in the heart exceeded that in the liver. Extracts of heart showed little enzymatic conversion of orotic acid to pyrimidine nucleotides in the presence of ATP and ribose-5-phosphate, a condition under which there was good activity in other tissues such as the liver, spleen, and kidney. Addition of phosphoribosylpyrophosphate (PRPP) markedly enhanced orotic acid conversion though it still remained less for heart than for other tissues. These findings indicated that PRPP synthetase activity was low in the heart. Uridine .kinase activity in the heart was similar to that in the liver. Uridine kinase appeared to be rate limiting in the "salvage" pathway. Aortic constriction produced an increase in uridine kinase activity at 24 hours with a peak at 2 to 6 days (50 to 60% stimulation) after operation, while uridylate kinase, uridine phosphorylase, and orotidine monophosphate pyrophosphorylase activities remained unchanged. The "salvage" pathway appears to play an important role in pyrimidine nucleotide synthesis in the heart, and uridine kinase may be regulatory in this pathway during cardiac hypertrophy.
ADDITIONAL KEY WORDS uridine kinase uridylate kinase uridine phosphorylase orotidine monophosphate pyrophosphorylase phosphoribosylpyrophosphate synthetase labeling of heart RNA uridine and orotic acid utilization by heart constriction of aorta enzymes in liver and skeletal muscle • Pyrimidine nucleotides are synthesized in several bacterial species, in yeast, and in a number of mammalian tissues through the de novo pathway, which consists of a series of reactions in which orotic acid is an intermediary (1) (2) (3) . The so-called "salvage" pathway (3) (4) (5) is available for reut ilization of the products of nucleic acid degradation. The salvage pathway appears to play an important role in pyrimidine nucleotide synthesis in certain bacterial species (6) and in various mammalian tumors (7, 8) . Although there is evidence for activity of the salvage pathway in several normal mammalian tissues, its role as a predominant pathway for the synthesis of pyrimidine nucleotides by these tissues has not been established.
A diagram of the de novo and salvage pathways of pyrimidine synthesis is shown in Figure 1 . After the formation of the pyrimidine base by a series of reactions in the de novo pathway, orotic acid is converted to OMP in the presence of OMP pyrophosphoryU ase. OMP is decarboxylated to UMP before further phosphorylation of UMP to UDP and UTP in the presence of uridylate kinase. In the salvage pathway, uracil may be converted to uridine by the enzyme, uridine phosphorylase. Uridine kinase catalyzes the formation of UMP from uridine. Uracil is also directly condensed with PRPP to form UMP in a reaction catalyzed by uracil phosphoribosyl transferase. However, this pathway is believed not to be active in mammalian tissues (9) .
During a series of experiments on the synthesis of nucleic acids, we found that orotic acid was a poor precursor for heart RNA, while it was incorporated very well into the RNA of other tissues such as the liver. On the other hand, labeling of RNA with uridine was relatively high in the heart. Although differences in transport across cell membranes and in intracellular pool sizes could account for this observation, it seemed equally plausible that the activities of various enzymes involved in the de novo and salvage pathways in the heart might differ from those in other tissues. Therefore, we undertook a study of several of the enzymes in the metabolic pathways of pyrimidine nucleotide synthesis and compared their activities in the heart with activities in other tissues. There was considerable enzymatic activity in the salvage pathway of pyrimidine nucleotide synthesis and low conversion of orotic acid to pyrimidine nucleotides by heart extracts under conditions in which there was active conversion by extracts from other tissues. These findings support the concept that the heart may utilize the salvage pathway to a large extent relative to the de novo one for the synthesis of pyrimidine nucleotides under normal conditions. Furthermore, there was a stimulation of the salvage pathway after aortic constriction as manifested by an increase in uridine kinase activity while enzymatic activity in the de novo pathway remained unchanged.
Methods and Materials

ANIMALS
Male albino rats were obtained from the Charles River Breeding Laboratories and maintained on Purina chow ad libitum. Aortic constrictions and sham operations were carried out as previously described (10) 
animals over a period of several days. These animals were all killed on the same day so that preparations and assays of all enzymes in each experiment could be performed simultaneously. Most experiments contained hearts from animals 2 hours and 1, 2, and 6 days after operation. A few experiments included animals 13 days after operation. Chloral hydrate (60 to 70 mg per animal) was given intraperitoneally for anesthesia. In some experiments in which the various enzymatic activities were characterized, animals up to 350 g in weight were used. All animals were killed by decapitation, and tissues were rapidly removed and kept in containers on ice until sliced or homogenized.
RADIOACTIVE LABELING OF RNA WITH : < H URIDINE, 3 H UMP, m URACIL AND 3H OROTIC ACID
For in-vitro experiments, tissue slices weighing approximately 200 to 400 mg were obtained with a Stadie-Riggs tissue slicer and were kept briefly in ice-cold saline until they were added to 10 ml of modified Krebs-Ringer bicarbonate medium, supplemented with amino acids, antibiotics and dextrose, to start the incubation. The incubation medium was prepared as follows: asparagine (2.5 mg), aspartic acid (2.5 mg), serine (15.4 mg), glutamic acid (9.1 mg), glycine (16.1 mg), alanine (21.4 mg), proline (13.9 mg), cysteine (3.0 mg), and tryptophan (5.0 mg) were added to 5.0 ml of Eagle's 100 X concentrated amino acid solution (Microbiological Associates, Inc.), and the pH was adjusted to 7.4 with NaOH. The amino acid mixture was diluted (1:100) with modified Krebs-Ringer bicarbonate (11) . The following substances were added to 100 ml of this solution: glutamine (29.2 mg), streptomycin (20 mg), penicillin (5,000 units), polymyxin B sulfate (1 mg), and dextrose (100 mg). Fifty micracuries of 3H uridine, 3 H UMP, or 3 H uracil or 100 fie of 3 H orotic acid were added to 100 ml of incubation medium. The final specific activity Circulation Research, Vol. XXVII, September 1970 of these compounds in the medium was made the same by the addition of unlabeled uridine, UMP, or uracil.
The incubation was carried out at 37°C in a Dubnoff metabolic shaker gassed with a 95% O2:5% CO2 mixture and was terminated by removing the tissue slices, washing them briefly with saline and homogenizing them by hand in 2 ml of ice-cold 10% trichloroacetic acid. The sediment was separated by centrifugation and was washed twice with ice-cold 10% trichloroacetic acid. It was then left overnight in 95% ethanol-5% K acetate (12) prior to two further washes with 95% ethanol. The sediment was dried in a desiccator. A sample of about 25 mg of sediment was extracted with 3 ml 10% NaCl (13) at 100°C for 60 minutes. RNA was precipitated by making the extract 68% in ethanol, and subsequently was washed with ethanol, dried, and dissolved in water. The amount of RNA present was estimated by measuring the optical density at 260 m/i. One optical density unit was equivalent to 32.2 mg • ml-1 • cm -1 (13) . A sample was counted in a Packard Tri-Carb liquid scintillation counter in scintillation fluid containing 0.5 g% 2-5-diphenyloxazole (PPO) and .04 g% l,4-bis-2-(5-phenyloxazolyl) benzene (POPOP) in toluene: 2-ethoxyethanol: :2:1. Specific activity was expressed as counts • min" 1 • mg-1 RNA.
For in-vivo experiments 3 H uridine, 3 H uracil, or 3 H orotic acid was injected intravenously in the tail vein and animals were killed 1 hour later. Organs were removed and tissue samples were handled as described above for the extraction of RNA and the measurement of its specific activity.
PREPARATION OF TISSUE EXTRACTS
Organs were removed, rinsed with homogenizing medium, blotted, weighed, and homogenized in three volumes of ice-cold . 02M (14) was used for homogenization. The homogenate was centrifuged in a Beckman Model L Ultracentrifuge at 100,000 X g for 90 minutes, and the supernatant fluid was carefully pipetted and used as the "tissue extract."
ENZYME ASSAYS
All assays were carried out at 37°C The reaction was started by the addition to the "tissue extract" and was terminated by adding l/20th volume of 100% trichloroacetic acid (w/v) to the incubation medium. After centrifugation, a sample of the supernatant fluid was added to an appropriate group of "carriers" (uracil, uridine, UMP, UDP, and UTP) whose final concentration was approximately 10~3M; and 10-20 /xliter of each sample was applied to one of the chromatographic systems described below. In cases where paper-strip chromatography was utilized, spots were identified under ultraviolet light, and areas of the strip were' cut out and counted directly in scintillation fluid containing 0.5 g% PPO and .04 g% POPOP in toluene in a Packard Tri-Carb liquid scintillation counter. Control samples without added extract were run routinely and subtracted as background. More than 95% of the radioactivity remained at the location of the substrate for all of the control samples. Enzymatic activity was expressed either as the percent of total counts on the chromatogram which were present in the product(s) of the reaction under analysis, or as the absolute quantities of the product(s) formed. All values expressed at a single time or concentration of enzyme activity were obtained under conditions in which there was relatively linear time and concentration dependence of the enzyme activity.
URIDINE KINASE ASSAY
The usual incubation was carried out by adding .05 to 0.1 ml of tissue extract to 0.5 ml of medium which contained .05M Tris-HCl, pH 7.8, .05M MgCl 2 , .005M ATP, 5 X 10" 5 M uridine, and 5 yuc/ml of 3 H uridine. After termination of the incubation, a sample was added to a mixture of unlabeled uracil, uridine, UMP, UDP, and UTP, and chromatography was carried out on strips of Whatman DE81 diethylaminoethyl cellulose paper in a descending system with a solvent containing 4N formic acid and 0.1N ammonium formate (15) . A 4-hour period provided good separation of all the above carriers except for uracil and uridine which had the same R ( value (Table 1) . Hence, it could not be determined with this system how much uridine was being converted to uracil. For separation of uracil and uridine, some samples also were chromatographed in the butanol system described below. Uridine kinase activity was determined from the total radioactivity in all uridine nucleotides at the end of incubation. Under the conditions and duration of our enzyme assay, no more than 15 to 20% of uridine was converted to uracil. This did not interfere with the linearity of uridine conversion to nucleotides. Also, under the conditions of the uridine kinase assay, the rate of backward conversion from UMP to uridine, as determined with 3 H UMP, never exceeded about 10% of that going in the forward direction. Although the kinetics of enzyme activity in the crude extract were somewhat complex, the multiplicity of reactions did not seem to interfere with the linearity of uridine kinase activity.
URIDYLATE KINASE ASSAY
The activity of uridylate kinase in the tissue extract was usually measured by the addition of 0.1 ml of extract to 0.5 ml of medium which contained .05M Tris-HCl, pH 7.8, .05M MgCl 2 , out on paper strips with the same system as that for uridine kinase, and uridylate kinase activity was expressed as UMP conversion to UDP plus UTP. With this assay, a small amount of radioactivity was also found in the uridine-uracil area; but under the conditions used, this was less than 20% of the total radioactivity and did not interfere with the linearity of the conversion of UMP to UDP plus UTP.
URIDINE PHOSPHORYLASE ASSAY
The conditions of the spectrophotometric assay described by Razzell (16) were modified for an assay which utilized the conversion of radioactive uridine to uracil. The incubation was carried out in a medium which contained .05M sodium arsenate-acetate buffer pH 7.5, 10~4M uridine and 1 fic/m\ 3 H uridine. The presence of arsenate makes this reaction irreversible since the arsenate combines with ribose formed from uridine. Separation of substrate and products was carried out either with ascending chromatography for 2K hours on thin-layer Eastman DEAE cellulose without fluorescent indicator or with descending chromato graphy for 15 hours on strips of Whatman 1 chroma to giaphy paper with a solvent system of water saturated n-butanol containing ammonium bicarbonate (17) ( Table 1) . Spots were identified under ultraviolet light. There was good separation of uracil and uridine from the nucleotides which remained at the origin. Areas of the thin-layer chroma to graphy were scraped oE and eluted with 1 ml of 0.1N HC1; 0.5 ml of the eluate was counted in scintillation fluid containing 0.04 g% POPOP:0.5 g% PPO in toluene : 2-ethoxyethanol:: 2:l. Areas of the paper chromato graphy strips were counted directly in scintillation fluid containing 0.04 g% POPOP and 0.5 g% PPO in toluene.
ASSAYS FOR CONVERSION OF OROTIC ACID
The conversion of orotic acid to various products by tissue extract was measured essentially in one of two ways-either in the presence of PRPP or with ATP and ribose-5phosphate added for the production of PRPP by enzymes in the extract. To measure the conversion of orotic acid in the presence of PRPP, .01 ml of extract was added to .05 ml of incubation medium containing .01M Tris-HCl, pH 7.4, .01M MgCU, 0.1M Na 2 HPO 4 , 5 X 10 -5 M orotic acid, .01M" PRPP and 4.4 /ic/ml of 24 3 H orotic acid. In these experiments, the reaction was stopped by adding an equal volume of a mixture of saturated (approximately .005M) orotic acid, .01M uridine, .01M UMP, and .01M EDTA, and by immediately cooling the sample 0°C.
For measurement without added PRPP, 0,1 ml of tissue extract was added to 0.5 ml of medium containing .01M Tris-HCl, pH 7.4, .01M MgCl2, September 1970 .03M phosphogly ceric acid, .01M Na 2 HPO 4 , 5 X 10" 5 M orotic acid, .01M ATP, .01M ribose-5phosphate, and 4.4 /i,c/ml of 3 H orotic acid. The reaction was stopped with trichloroacetic acid as noted above.
Descending chromato graphy was carried out for 16 hours on strips of Whatman DE81 diethylaminoethyl cellulose chromatography paper with an ammonium acetate: ethanol:H 2 O solvent system as described by Skold (18) . Good resolution of orotic acid, uridine-uracil, and uridine nucleotides was obtained ( Table 1) . No more than approximately 1% of the counts was in the area of dihydroorotic acid. Radioactivity was distributed in UDP, UTP and uridine-uracil as well as UMP, and we elected to express the results as total percent conversion of orotic acid (100% minus % of total radioactivity remaining in orotic acid).
The assay system containing PRPP was considered to measure orotidine monophosphate (OMP) pyrophosphorylase. We were unable to obtain OMP decarboxylase in a purified form to be sure that the amount of this enzyme added with the tissue extract was in excess, but assume that it was since: (1) the conversion of orotic acid was linear over the time periods used, and it would be expected that this would not occur if OMP accumulated; and (2) most radioactivity was found in the area of UTP when ATP was added. The assav system in the presence of ATP and ribose-5-ohosphate is a measure of endogenous PRPP plus PRPP formed during incubation. Since there was very little, if any. conversion of orotic acid to nucleotides for any of the tissues without either ATP and ribose-5phosphate or PRPP, orotic acid conversion in the presence of ATP and ribose-5-phosphate reflected PRPP synthetase activity. 
Results
Incorporation of Labeled Precursors into
FIGURE 2
Labeling of RNA in vitro and in vivo. In-vitro labeling of RNA of tissue slices was carried out as described in Methods. The concentrations of the labeled substrates were as follows: orotic acid (1.2 x 10~SM); undine (5.9 X 10->'M); UMP (5.6 X 10-'IM); and uracil (5.9 X 10-*M). Specific activity was 0.83 c/mmole for each of these substances. For in-vivo labeling, animals were injected with 0.5 me of S H orotic acid or 0.25 me of 3 H uridine or S H uracil. The absolute quantity of labeling with uridine or uracil was multiplied by two so as to make the original doses of radioactivity equivalent to that of S H orotic acid.
acid, uridine, UMP, and uracil into RNA of tissue slices. The specific activity of these compounds was adjusted so as to make them all equal in the medium at the time of the start of the incubation. Relative to the liver, there was little orotic acid incorporation into RNA of the heart. On the other hand, labeling of heart RNA with uridine or UMP was high relative to that of the liver, and labeling with uridine exceeded that with orotic acid in the heart. There was little incorporation of uracil into RNA for either the heart or the liver. Incorporation of Labeled Precursors into RNA in Vivo.-The relative incorporation of radioactive precursors into RNA in vivo (Fig.  2 ) reflected the pattern found in vitro. In vivo there was considerably more incorporation of orotic acid into RNA of liver than into that of heart. The uridine incorporation into RNA of liver was less than 1% of that of orotic acid incorporation. Labeling of heart RNA with uridine exceeded that for liver and was several times more than orotic acid labeling of heart RNA. As noted in the in-vitro studies, labeling with uracil was relatively low for both the heart and the liver.
Enzymes of Pyrimidine Synthesis.- Figure  3 Enzyme activities in heart extract at varying substrate concentrations. Assays were carried out as described in Methods. For OMP pyrophosphorylase activity, the assay media contained 10~SM PRPP. The substrates which were varied are as follows: for uridylate kinase, UMP; for uridine phosphorylase, uridine; for OMP pyrophosphorylase, orotic acid; and for uridine kinase, uridine. both heart and skeletal muscle showed little activity in the conversion of orotic acid in the presence of ATP and ribose-5-phosphate without added PRPP ( Table 2 ). Extracts of several other tissues showed relatively good orotic acid conversion under these conditions. There was little, if any, activity in any of the extracts without the addition of ATP and ribose-5-phosphate or PRPP. Orotic acid conversion by heart extract was enhanced markedly with the addition of PRPP. Nevertheless, the activity in heart was only oneninth that in the liver even in the presence of PRPP. The finding of low orotic acid conversion by the heart in the presence of ATP and ribose-5phosphate suggests that there was low PRPP synthetase activity in the heart extract. To eliminate the possibilities of degradation of PRPP synthetase during tissue homogenization or instability of PRPP in the presence of heart extract during incubation, the following experiments were performed: (1) Mixtures of heart and liver tissue were homogenized together and were found to yield additive activities of the extract (Fig. 4) ; and (2) PRPP was preincubated with heart extract before its use in measuring orotic acid conversion by liver extract, and no evidence was found for inactivation of PRPP by the heart extract ( Fig. 5 ). It was also considered that ATP might be destroyed in the assay system by heart extract. However, examination of a chromatogram of a sample of the postincubation medium under ultraviolet light showed no evidence for destruction of ATP. Figure 6 shows substrate concentration heart. The reason for the requirement for high concentrations of PRPP for enzyme saturation in the crude extract was unclear. Uridine Kinase Activity of the Heart.-Uridine kinase activity in heart extracts was relatively low compared with the activities of uridylate kinase and uridine phosphorylase (Fig. 3) . This is consistent with the impression that uridine kinase is rate-limiting in the salvage pathway for the synthesis of uridine nucleotides (20) (21) (22) . Extracts of various tissues were compared for uridine kinase activity, and it was found that the activity in heart was similar to that in liver and somewhat higher than that in skeletal muscle, although it was lower than the activity in other tissues such as the kidney and spleen ( Table 2 ). Figure 7 shows substrate concentration curves and Lineweaver-Burk plots for uridine kinase activity of the heart extract. The Km for uridine as substrate was 3.4 X 10" 5 M, and the Km for ATP as substrate was 2.7 X 10"3M.
Skold previously reported the Km for uridine for uridine kinase activity in Ehrlich ascites cells to be 4.8 X 10" 5 M and the Km for ATP to be5xlO-4M (23) .
Uridine kinase activity has been found to be subject to end product inhibition by UTP and CTP in mouse mast cell neoplasm, human epidermoid carcinoma, and Novikoff ascites rat tumor (22, 24) . The effect of UTP, CTP and GTP on uridine kiriase activity of heart extracts was tested. While there was little, if any, effect of GTP on enzymatic activity, both UTP and CTP produced marked inhibition of uridine kinase activity (Fig. 8) .
Uridylate Kinase Activity.-When measuring uridine kinase activity, we found that the distribution of radioactivity in UMP, UDP, and UTP was at times quite variable and unpredictable even though the sum of the counts in these three nucleotides remained unchanged. Further studies showed that in the presence of EGTA, there was an increase in labeling of UTP and UDP and a decrease in labeling of UMP ( Fig. 9A and B) . It was of interest that this pattern could be reversed with the bulk of labeling in UMP, and little labeling of UDP and UTP when high concentrations of calcium were added to the incubation medium (Fig. 9B ). Hence, it appeared that some substance in the tissue extract, which could be chelated, was inhibitory for uridylate kinase activity. Since relatively large amounts of calcium were necessary to reverse the EGTA effect, it was uncertain whether calcium was the inhibitor. EGTA was added routinely in assays for uridylate kinase activity. Under these condi- [PRPP](mM) OMP pyrophosphorylase activity of heart extract at various substrate concentrations. A: Orotic acid concentrations were varied and conversion of orotic acid was measured. Assays were carried out as described in Methods in the presence of .01M PRPP. The insert shows a Lineweaver-Burk plot from which the apparent Km was calculated. B: PRPP concentrations were varied and conversion of orotic acid was measured. Assays were carried out as described in Methods in the presence of 5 X 10~5M orotic acid. The insert shows a Lineweaver-Burk plot from which the apparent Km was calculated.
tions, the activity of uridylate kinase was very high in heart extracts (Fig. 3) . times after aortic constriction. The results of this study, are shown in Table 3 and Figure 10 . There was a significant increase in the uridine kinase activity in heart extracts at 24 hours after aortic constriction, and this reached a peak level of 50to60% above controls between 2 and 6 days after operation. There was no Uridine kinase activity of heart extract at various substrate concentrations. A: Uridine concentrations were varied and conversion of uridine was measured. Assays were carried out as described in Methods. The concentration of ATP was .005M. The insert shows a Lineweaver-Burk plot from which the apparent Km was calculated. B: ATP concentrations were varied and conversion of uridine was measured. Assays were carried out as described in Methods. The concentration of uridine was 5 X 10~5M. The insert shows a Lineweaver-Burk plot from which the apparent Km was calculated.
Effect of Aortic Constriction on Activities of Enzymes of Pyrimidine
increase in uridine kinase activity at 2 hours after constriction. Since animals were still subdued at 2 hours when given intraperitoneal chloral hydrate, some experiments were carried out with animals given ether anesthesia, and there was still no change in uridine kinase activity at 2 hours after constriction. In contrast to the increase in uridine kinase activity, there was no significant increase in the activities of uridylate kinase, uridine phosphorylase, or OMP pyrophosphorylase after aortic constriction.
Discussion
These studies show little incorporation of orotic acid as compared to that of uridine into heart RNA. Pool size, compartmentalization, and membrane transport, as well as enzyme activities, might affect the final specific activity of RNA. The present studies have focused on the relative activities of enzymes of the de novo and salvage pathways of pyrimidine nucleotide synthesis in the heart. Uridine phosphorylase and uridylate kinase activities are high and uridine kinase activity appears to be rate-limiting in the salvage pathway, which is in accord with previous findings in other tissues (20) (21) (22) . The maximum enzymatic activity of OMP pyrophosphorylase is about the same as that of uridine kinase in the heart extract. However, there are somewhat different Km's for these enzymes, and the relative activities of the enzymes would depend to a large extent upon the relative substrate concentrations in the cell. OMP pyrophosphorylase activity was several-fold higher for liver than for heart and could explain, at least in part, the higher labeling of liver with H orotic acid if it were assumed that the substrate concentrations in the two tissues were similar.
There was little conversion of orotic acid to pyrimidine nucleotides by extracts of heart or skeletal muscle in the presence of ATP and ribose-5-phosphate, a condition under which there was considerable conversion of orotic acid by extracts of other mammalian tissues. A Distribution of radioactivity in UMP, UDP and UTP after incubation of heart extract with S H uridine or "H UMP. A: Incubation medium contained constituents described under "uridine kinase assay" in Methods. 0.1 ml of heart extract was added to 1.25 ml of medium, and the incubation was carried out for 30 minutes. B: Incubation medium contained constituents described under "uridylate kinase assay" in Methods.
EGTA was present at a final concentration of 5 x 10-'IM. 0.05 ml of heart extract was added to 0.6 ml of medium, and the incubation was carried out for 30 similar observation for rat heart and skeletal muscle was made previously by Hurlbert and Reichard (25) . However, they did not assess the effect of added PRPP in their assay system. Our experiments showed marked stimulation of orotic acid conversion by heart extract with the addition of PRPP and suggested that the primary limitation in this reaction resulted from low PRPP synthetase activity in the heart extract. We found no evidence for destruction of PRPP synthetase during preparation of the extract or for instability of PRPP in enzyme assays which utilized heart extract. The low orotic acid conversion in the presence of ATP and ribose-5-phosphate was not specific for rat heart since relatively low activity was found also in extracts from mouse or guinea pig heart (unpublished data.) Whether or not the low labeling of RNA with orotic acid is a function of relatively low PRPP in heart tissue remains to be established. The enzyme data combined with the relatively high labeling of heart RNA with "H uridine suggest an important role for the salvage pathway in the synthesis of pyrimidine nucleotides in the heart. An exact quantitative assessment of the relative importance of the de novo and salvage pathways in the intact heart cannot be derived from the present data since there is no information about the relative transport of precursors or pool sizes within the tissues.
The regulation of the enzymes of the de novo and salvage pathways of pyrimidine nucleotide synthesis is of interest. Feedback inhibition has been studied extensively for these enzymes (22) (23) (24) (26) (27) (28) . It has been demonstrated in systems other than the heart that uridine kinase activity is regulated by UTP and CTP (22) (23) (24) . Carbamyl-aspartate transferase, carbamyl-phosphate synthetase, and OMP decarboxylase, enzmyes in the de novo pathway, are also subject to feedback inhibition (26) (27) (28) . PRPP synthetase is subject to inhibition by various compounds including ADP, CTP, UTP, GDP, 1-3-diphosphoglyceric acid, and tryptophan (29, 30) . It appears from the present studies that heart uridine kinase activity may be regulated by UTP and CTP. The regulation of the other enzymes has not been studied for the heart.
Aortic constriction produced a stimulation of uridine kinase activity while uridine phosphorylase, uridylate kinase, and OMP pyrophosphorylase activities remained unaltered. At present we are investigating the effect of constriction on PRPP synthetase activity. There is no information available on the effect of aortic constriction on the enzymes in the earlier portion of the de novo pathway. Koide and Rabinowitz reported a 50% increase in total uridine nucleotides at 48 hours after aortic constriction in the rat (31) , and an increase in uridine kinase may regulate the increase in nucleotides.
The apparent selective stimulation of uridine kinase activity in the hypertrophying heart resembles the response seen in phytohemagglutin-induced RNA synthesis in lymphocytes (32) . On the other hand, during liver regeneration, there is a marked increase in the activities of enzymes of both the de novo and salvage pathways (17) and, in particular, an early increase in OMP pyrophosphorylase (33) .
If the salvage pathway does play an important role in pyrimidine nucleotide synthesis in the heart, the origin of the substrate for this pathway is not clear at present. Despite high uridine phosphorylase activity, uracil was incorporated very poorly into heart RNA as well as into that of other rat tissues. Canellakis has explained the failure to incor- Research, Vol. XXVll, September 1970 porate uracil into liver RNA as being due to high catabolic activity for uracil in the liver (34) , and this explanation, although untested, may also apply for the heart. Our experiments indicate that uridine is more favorable than uracil as a substrate for the formation of pyrimidine nucleotides by the heart. Either dietary uridine or endogenous uridine formed from uridine nucleotide pools in other tissues could be utilized by the heart. There is at present no supporting evidence for the speculation that the heart may derive uridine from other organs. However, the postulation that one tissue may be dependent upon a nucleoside produced in another has a precedent in experiments done by Lajthe and Vane in which they found that bone marrow is dependent upon the liver for its supply of purines (35) .
Skeletal muscle resembled the heart in its conversion activities for uridine kinase and orotic acid. Further studies are needed to determine the degree of similarity between heart and skeletal muscle in pyrimidine metabolism.
